XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 131 filers reported holding XENON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,071,666 | -11.4% | 236,290 | -0.2% | 0.29% | +2.9% |
Q2 2023 | $9,114,991 | -7.7% | 236,753 | -14.2% | 0.28% | -7.0% |
Q1 2023 | $9,878,469 | -22.7% | 276,012 | -14.9% | 0.30% | -23.0% |
Q4 2022 | $12,785,178 | +18.1% | 324,250 | +8.1% | 0.39% | +10.8% |
Q3 2022 | $10,825,000 | +25.0% | 299,855 | +5.3% | 0.35% | +19.3% |
Q2 2022 | $8,663,000 | +7.9% | 284,772 | +8.4% | 0.30% | +48.7% |
Q1 2022 | $8,031,000 | +18.3% | 262,705 | +20.9% | 0.20% | +42.1% |
Q4 2021 | $6,788,000 | +429.9% | 217,301 | +159.1% | 0.14% | +483.3% |
Q3 2021 | $1,281,000 | -17.4% | 83,854 | +0.7% | 0.02% | -17.2% |
Q2 2021 | $1,550,000 | +4.2% | 83,249 | +0.2% | 0.03% | -9.4% |
Q1 2021 | $1,487,000 | -36.9% | 83,088 | -45.8% | 0.03% | -39.6% |
Q4 2020 | $2,358,000 | +34.2% | 153,321 | -3.4% | 0.05% | -11.7% |
Q3 2020 | $1,757,000 | +26.2% | 158,704 | +43.0% | 0.06% | +20.0% |
Q2 2020 | $1,392,000 | +10.6% | 110,999 | 0.0% | 0.05% | -26.5% |
Q1 2020 | $1,259,000 | -10.1% | 110,999 | +3.9% | 0.07% | +6.2% |
Q4 2019 | $1,401,000 | +46.1% | 106,839 | +0.4% | 0.06% | +20.8% |
Q3 2019 | $959,000 | -1.0% | 106,459 | +8.3% | 0.05% | +10.4% |
Q2 2019 | $969,000 | -12.2% | 98,259 | -9.6% | 0.05% | -18.6% |
Q1 2019 | $1,104,000 | – | 108,679 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |